Agenus (AGEN) Current Deferred Revenue (2010 - 2025)
Agenus (AGEN) reported Current Deferred Revenue of $45,000 for Q3 2025, up 350.0% from $10,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Agenus (AGEN) Current Deferred Revenue (2010 - 2025) Analysis & Trends
At the end of FY2024, Agenus posted Current Deferred Revenue of $31,000, up 72.2% from FY2023.
- Current Deferred Revenue has a five-year compound annual growth rate of -74.6% (FY2019 to FY2024).
- By year, Current Deferred Revenue came in at $18,000 in FY2023 (-99.9%), $12.27 million in FY2022 (-1.3%), $12.43 million in FY2021 (-27.7%) and $17.19 million in FY2020 (-41.1%).
- Five-year quarterly Current Deferred Revenue spans a low of $9,000 in Q2 2024 and a high of $28.15 million in Q2 2021.
- Year over year, Current Deferred Revenue has now increased in each of the last four quarters, with growth averaging 53.8% over the last eight quarters.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2025 (growth of 400.0%); the low point was Q2 2024 (a decline of 99.9%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $45,000 (Q2 2025), $14,000 (Q1 2025) and $31,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Agenus | 423.17 Mn | 416.40 Mn | 34.52 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 31,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 4.99 Mn |
| Jun 30, 2023 | 7.83 Mn |
| Mar 31, 2023 | 9.89 Mn |
| Dec 31, 2022 | 12.27 Mn |
| Sep 30, 2022 | 12.76 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 13.53 Mn |
| Dec 31, 2021 | 12.43 Mn |
| Sep 30, 2021 | 19.68 Mn |
| Jun 30, 2021 | 28.15 Mn |
| Mar 31, 2021 | 22.83 Mn |
| Dec 31, 2020 | 17.19 Mn |
API Access
Agenus Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AGEN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "AGEN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AGEN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();